1. Home
  2. CWD vs HSCS Comparison

CWD vs HSCS Comparison

Compare CWD & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CaliberCos Inc.

CWD

CaliberCos Inc.

HOLD

Current Price

$1.22

Market Cap

10.8M

Sector

Finance

ML Signal

HOLD

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

HOLD

Current Price

$2.79

Market Cap

9.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWD
HSCS
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
9.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CWD
HSCS
Price
$1.22
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.20
AVG Volume (30 Days)
57.1K
13.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,119,000.00
N/A
Revenue This Year
N/A
$1,072.41
Revenue Next Year
$26.79
$2,700.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$2.01
52 Week High
$46.21
$6.47

Technical Indicators

Market Signals
Indicator
CWD
HSCS
Relative Strength Index (RSI) 45.16 40.86
Support Level $1.16 $2.72
Resistance Level $1.54 $3.00
Average True Range (ATR) 0.10 0.12
MACD 0.02 -0.03
Stochastic Oscillator 45.77 2.34

Price Performance

Historical Comparison
CWD
HSCS

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: